Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shashank R Joshi

Showing results (151-160 of 178) with videos related to

Pageof 18
Sort By:
Indian Journal of Endocrinology and Metabolism|December 11, 2012
Suggested use of vaccines in diabetesJothydev Kesavadev, Anoop Misra, Ashok Kumar Das, et al.
The International Journal of Pharmacy Practice|April 27, 2023
Ten clinical pharmacological interventions in routine care to ensure better treatment outcomesSaibal Das, Shambo Samrat Samajdar, Shatavisa Mukherjee, et al.
The Journal of the Association of Physicians of India|May 22, 2022
Indian Reality of Clinical Practice and Patient Profile in Diabetes Care: Lessons from the IMPACT surveyShashank R Joshi, Subhash K Wangnoo, Subhankar Chowdhury, et al.
The Journal of the Association of Physicians of India|January 13, 2018
Role and Relevance of Blood Pressure Variability in Hypertension Related Co-morbiditiesAshok Kumar, B C Kalmath, Georgi Abraham, et al.
Infectious Diseases and Therapy|February 18, 2022
Efficacy and Safety of a Phytopharmaceutical Drug Derived from Cocculus hirsutus in Adults with Moderate COVID-19: a Phase 2, Open-label, Multicenter, Randomized Controlled TrialSadhna Joglekar, Shivakumar S Iyer, Rohit Parate, et al.
Diabetology & Metabolic Syndrome|January 11, 2026
Efficacy and safety of fixed-dose dapagliflozin-pioglitazone in Indian adults with type 2 diabetes: results from the randomized phase 3 PRO-1 trialAwadhesh Kumar Singh, Krishna G Seshadri, A G Unnikrishnan, et al.
The Journal of the Association of Physicians of India|July 11, 2009
Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitusM Prashanth, H K Ganesh, M V Vima, et al.
BMJ Open|November 2, 2014
Results from a dietary survey in an Indian T2DM population: a STARCH studyShashank R Joshi, Anil Bhansali, Sarita Bajaj, et al.
Diabetes Technology & Therapeutics|May 23, 2017
Role of Continuous Glucose Monitoring in Clinical Trials: Recommendations on ReportingOliver Schnell, Katharine Barnard, Richard Bergenstal, et al.
Diabetes Technology & Therapeutics|February 6, 2026
Standardizing the Accuracy and Performance Evaluation Metrics of Integrated Continuous Glucose Monitors in the Asia-Pacific RegionAlice Pik-Shan Kong, Rimei Nishimura, Stephen M Twigg, et al.
Pageof 18

Showing results (151-160 of 178) with videos related to

Sort By:
Pageof 18
Indian Journal of Endocrinology and Metabolism|December 11, 2012
Suggested use of vaccines in diabetesJothydev Kesavadev, Anoop Misra, Ashok Kumar Das, et al.
The International Journal of Pharmacy Practice|April 27, 2023
Ten clinical pharmacological interventions in routine care to ensure better treatment outcomesSaibal Das, Shambo Samrat Samajdar, Shatavisa Mukherjee, et al.
The Journal of the Association of Physicians of India|May 22, 2022
Indian Reality of Clinical Practice and Patient Profile in Diabetes Care: Lessons from the IMPACT surveyShashank R Joshi, Subhash K Wangnoo, Subhankar Chowdhury, et al.
The Journal of the Association of Physicians of India|January 13, 2018
Role and Relevance of Blood Pressure Variability in Hypertension Related Co-morbiditiesAshok Kumar, B C Kalmath, Georgi Abraham, et al.
Infectious Diseases and Therapy|February 18, 2022
Efficacy and Safety of a Phytopharmaceutical Drug Derived from Cocculus hirsutus in Adults with Moderate COVID-19: a Phase 2, Open-label, Multicenter, Randomized Controlled TrialSadhna Joglekar, Shivakumar S Iyer, Rohit Parate, et al.
Diabetology & Metabolic Syndrome|January 11, 2026
Efficacy and safety of fixed-dose dapagliflozin-pioglitazone in Indian adults with type 2 diabetes: results from the randomized phase 3 PRO-1 trialAwadhesh Kumar Singh, Krishna G Seshadri, A G Unnikrishnan, et al.
The Journal of the Association of Physicians of India|July 11, 2009
Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitusM Prashanth, H K Ganesh, M V Vima, et al.
BMJ Open|November 2, 2014
Results from a dietary survey in an Indian T2DM population: a STARCH studyShashank R Joshi, Anil Bhansali, Sarita Bajaj, et al.
Diabetes Technology & Therapeutics|May 23, 2017
Role of Continuous Glucose Monitoring in Clinical Trials: Recommendations on ReportingOliver Schnell, Katharine Barnard, Richard Bergenstal, et al.
Diabetes Technology & Therapeutics|February 6, 2026
Standardizing the Accuracy and Performance Evaluation Metrics of Integrated Continuous Glucose Monitors in the Asia-Pacific RegionAlice Pik-Shan Kong, Rimei Nishimura, Stephen M Twigg, et al.
Pageof 18